Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Genitourinary System Neoplasm — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Site
Genitourinary System Neoplasm

Cancer Family

Genitourinary System Neoplasm

CI-CAN-00000018Explore in graph →

Non-malignant3,846 active trials61 approved drugs306 evidence items

NCIt: C156482

Overview
Statistics
Survival
Genomics114
Variants & evidence306
Drugs75
Trials17382
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

17,382 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

StatusAll Active (any)Completed 7,606 Recruiting 2,755 Unknown 2,337 Terminated 1,744 Active Not Recruiting 1,312 Not Yet Recruiting 788 Withdrawn 632 Enrolling By Invitation 83 Suspended 70 No Longer Available 26 Available 14 Approved For Marketing 14 Temporarily Not Available 1

PhaseAll Early Phase 1 281 N/A 3,908 Phase 1 3,193 Phase 2 5,800 Phase 3 1,601 Phase 4 293

No study matches these filters